Table 1. List of genomic regions validated as driving muscle-specific expression.
Coordinates | Prediction Method | |||||||
Set | Chr | Prediction | Insert | Gene Name | Positive Wells | C. Buster | LRA | MSCAN |
BG | 11 | 116201218–116201584 | 116201218–116201584 | APOA4; APOC3 | 4/5 | |||
BG | 11 | 1721407–1721765 | 1721407–1721765 | HCCA2 | 3/6 | C | ||
BG | 11 | 66008803–66009164 | 66008803–66009164 | DPP3 | 2/2 | |||
BG | 11 | 71615350–71615709 | 71615350–71615709 | INPPL1 | 2/2 | |||
NM | 15 | 83185168–83185457 | 83184998–83185491 | ALPK3 | 2/2 | C | L | M |
NM | 18 | 40637176–40637555 | 40637097–40637579 | SETBP1 | 3/4 | C | L | M |
NM | 22 | 22516591–22516990 | 22516569–22517062 | DERL3; SLC2A11 | 10/11 | C | L | M |
NM | 22 | 22883635–22883974 | 22883584–22884017 | CABIN1 | 2/4 | C | L | M |
M | 1 | 119250477–119250882 | 119250477–119250882 | TBX15 | 2/2 | C | L | M |
M | 1 | 199612030–199612429 | 199611961–199612457 | TNNT2 | 2/4 | C | M | |
M | 2 | 144878638–144878867 | 144878533–144878970 | ZEB2 | 2/2 | C | M | |
M | 2 | 88147937–88148156 | 88147915–88148315 | SMYD1 | 4/4 | L | ||
M | 4 | 37728510–37728799 | 37728494–37728957 | TBC1D1 | 2/4 | L | M | |
M | 6 | 42106432–42106831 | 42106373–42106867 | CCND3 | 2/2 | C | L | M |
M | 6 | 7127465–7127684 | 7127364–7127817 | RREB1 | 2/4 | L | M | |
M | 9 | 35677988–35678317 | 35677887–35678364 | TPM2 | 6/9 | C | L | |
M | 14 | 104259446–104259775 | 104259362–104259861 | INF2; ADSSL1 | 2/3 | C | L | |
M | 19 | 3326530–3326884 | 3326530–3326884 | NFIC | 4/4 | L | M | |
M | 19 | 54184895–54185244 | 54184834–54185225 | GYS1 | 2/3 | C | L | M |
Gene names were chosen for their proximity to the regions of interest (UCSC hg18). ‘Positive Wells’ column shows the number of replicates that were classified as positive out of all replicates for the sequence. Columns ‘C.Buster,’ ‘LRA,’ and ‘MSCAN’ indicate programs which predicted a CRM in the given region.